STOCK TITAN

INSTITUTE OF BIOMED RESH - MRES STOCK NEWS

Welcome to our dedicated page for INSTITUTE OF BIOMED RESH news (Ticker: MRES), a resource for investors and traders seeking the latest updates and insights on INSTITUTE OF BIOMED RESH stock.

Institute of Biomedical Research Corp is a pioneering nutraceutical biotechnology company headquartered in Montenegro, leading the field in alternative plant-based cannabinoids and medical psilocybin research. Their core focus on mental health therapeutic research, powered by cutting-edge artificial intelligence (AI), sets them apart in the industry. The M2Biome division, a vital aspect of their operations, is dedicated to offering evidence-based, sustainable products catering to individual needs effectively. Over the recent years, the company has witnessed significant growth and achievements, venturing into diverse product ranges and expanding its global market outreach.

Rhea-AI Summary
Institute of Biomedical Research Corp. (OTC PINK:MRES) held the Annual Biomedical Research & Innovation Platform Symposium. Prof Vinesh Maharaj discussed the potential of plant-based medicine and the use of artificial intelligence in drug development. The University of Pretoria is working on establishing a comprehensive plant database and high-throughput screening method. They have found African ginger to be effective against SARS-CoV-2 and influenza. The university has filed a patent for using African ginger in the fight against COVID-19.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
none
-
Rhea-AI Summary
Institute of Biomedical Research Corp. announces update with M2MMA division
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.85%
Tags
management
-
Rhea-AI Summary
Institute of Biomedical Research Corp. (OTC PINK:MRES) announces Professor Vinesh Maharaj as keynote speaker at the 13th Annual Biomedical Research & Innovation Platform Symposium. Prof. Maharaj will cover 'African Traditional Medicine: Past, Present, and Future Perspectives' and explore AI-driven phytomedicine research. The event promises to offer insights into the latest trends, innovations, and investment prospects in the biomedical field.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8%
Tags
none
News
Rhea-AI Summary
Institute of Biomedical Research Corp. announces completion of the acquisition of Crypto Exchange JDAX and plans to rebrand and relocate to Dubai.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.86%
Tags
-
Rhea-AI Summary
Institute of Biomedical Research Corp. (OTC PINK:MRES) provides webinar update on CBD's pharmacology and clinical application. CBD's non-intoxicating nature and potential therapeutic applications highlighted. Limited studies available for general treatment. Webinar aims to educate healthcare professionals. Recording available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.77%
Tags
none
-
Rhea-AI Summary
Institute of Biomedical Research Corp. presents groundbreaking update on drug discovery using AI. AI can expedite and make drug discovery more cost-effective. M2Bio Sciences invests in AI for holistic health approach. Positive impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.53%
Tags
AI
Rhea-AI Summary
M2Bio Sciences, a nutraceutical biotechnology company specializing in alternative plant-based cannabinoids and medical psilocybin, has introduced its Mixed Martial Arts Organization called 'M2 MMA'. The organization will promote events in the UAE, Thailand, and South Africa, combining the expertise of M2Bio Sciences in drug discovery and mental health with combat sports. M2Bio Sciences aims to provide compassionate and respectful treatment to fighters, addressing inflammatory conditions and cerebral injuries. The CEO expressed excitement about expanding the company's global footprint and elevating the physical and mental dimensions of athletes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.09%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary
Institute of Biomedical Research Corp. (OTC PINK: MRES) announces the forthcoming launch of a line of Purple, White, and Green teas sourced from Kenya. The teas offer exceptional health benefits and are crafted in collaboration with esteemed tea experts. Purple Tea supports cardiovascular health and healthy aging, White Tea aids in detoxification and provides anti-aging benefits, and Green Tea promotes heart health and cognitive function.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of INSTITUTE OF BIOMED RESH (MRES)?

The current stock price of INSTITUTE OF BIOMED RESH (MRES) is $0.0048 as of October 14, 2024.

What is the market cap of INSTITUTE OF BIOMED RESH (MRES)?

The market cap of INSTITUTE OF BIOMED RESH (MRES) is approximately 11.1M.

Where is Institute of Biomedical Research Corp. located?

Institute of Biomedical Research Corp is headquartered in Montenegro.

What is the core focus of the company?

The company specializes in nutraceutical biotechnology, with a strong emphasis on alternative plant-based cannabinoids, medical psilocybin, and mental health therapeutic research driven by artificial intelligence (AI).

What is the M2Biome division responsible for?

The M2Biome division focuses on providing evidence-based, sustainable products tailored to meet individual health needs effectively.

What recent achievements has the company made?

In the recent years, the company has experienced significant growth, diversified its product offerings, and expanded its global market presence.

How does the company's AI-driven research set them apart?

The utilization of cutting-edge artificial intelligence (AI) in their mental health therapeutic research and product development differentiates Institute of Biomedical Research Corp in the industry.

INSTITUTE OF BIOMED RESH

OTC:MRES

MRES Rankings

MRES Stock Data

11.15M
Biotechnology
Healthcare
Link
United States of America
Podgorica